Richard Eisenstadt

2017 - Neos Therapeutics

In 2017, Richard Eisenstadt earned a total compensation of $704.9K as Chief Financial Officer at Neos Therapeutics, a 4% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$65,728
Option Awards$180,883
Salary$339,771
Stock Awards$105,000
Other$13,522
Total$704,904

Eisenstadt received $339.8K in salary, accounting for 48% of the total pay in 2017.

Eisenstadt also received $65.7K in non-equity incentive plan, $180.9K in option awards, $105K in stock awards and $13.5K in other compensation.

Rankings

In 2017, Richard Eisenstadt's compensation ranked 10,582nd out of 14,666 executives tracked by ExecPay. In other words, Eisenstadt earned more than 27.8% of executives.

ClassificationRankingPercentile
All
10,582
out of 14,666
28th
Division
Manufacturing
4,118
out of 5,772
29th
Major group
Chemicals And Allied Products
1,468
out of 2,075
29th
Industry group
Drugs
1,199
out of 1,731
31st
Industry
Pharmaceutical Preparations
933
out of 1,333
30th
Source: SEC filing on April 30, 2018.

Eisenstadt's colleagues

We found two more compensation records of executives who worked with Richard Eisenstadt at Neos Therapeutics in 2017.

2017

Vipin Garg

Neos Therapeutics

Chief Executive Officer

2017

Tom McDonnell

Neos Therapeutics

Chief Commercial Officer

News

You may also like